PERRIGO Co plc 8-K

What Happened

• Perrigo Co plc announced on April 30, 2026 that it closed the previously disclosed sale of its Dermacosmetics business (including all shares of Aco Hud Nordic AB and related assets for Northern Europe, the Netherlands and Poland) to Karo Healthcare AB (via Kairos Bidco AB / Karo), effective under a Master Sale and Purchase Agreement dated July 13, 2025.
• At closing Karo paid Perrigo €305.6 million in cash (this amount includes €5.6 million attributable to net working capital adjustments). Perrigo may also receive up to €27.0 million in contingent cash consideration based on the Dermacosmetics business meeting certain performance thresholds over a three‑year period.
• The transaction closing and the assignment/assumption of rights from Kairos to Karo were completed on April 30, 2026. Perrigo issued a press release on the same date announcing the closing (Exhibit 99.1 to the 8‑K).

Key Details

• Buyer: Karo Healthcare AB (transaction executed via Kairos Bidco AB, with Karo assuming rights/obligations).
• Target/business sold: Aco Hud Nordic AB and related Dermacosmetics assets for Northern Europe, the Netherlands & Poland.
• Consideration: €305.6 million cash at closing (includes €5.6M net working capital adjustment); up to €27.0M contingent over three years.
• Agreement date: Master Sale and Purchase Agreement dated July 13, 2025; closing date: April 30, 2026.

Why It Matters

• The sale reduces Perrigo’s exposure to its Dermacosmetics operations in the specified European markets and provides immediate cash proceeds of €305.6M, which can affect the company’s liquidity and capital allocation.
• Contingent consideration (up to €27M) ties additional potential proceeds to future performance of the sold business, but is not guaranteed.
• Investors should view this as a portfolio simplification/strategic divestiture that may impact Perrigo’s revenue mix and future growth profile in cosmetics-related segments; review Perrigo’s ongoing disclosures and earnings reports for any changes to guidance or use of proceeds.